Research News
The National Institutes of Health awarded a research team at GW $7.8 million to establish a rare disease network for myasthenia gravis.
Nathaniel DeNicola, MD, co-authored a review article on environmental exposures on reproductive health and how OB-GYNs can work with their patients to ensure safe pregnancies. The piece is published in Obstetrics and Gynecology Clinics of North America.
During a symposium on correctional policy, practice, and care for incarcerated members of the transgender community, held at the GW, stakeholders found that collaborative engagement could help further guidance for this vulnerable population.
The AIDS and Cancer Specimen Resource has been renewed for five years with GW serving as the primary site.
GW Cancer Center researchers found that PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.
Raja Mazumder, PhD, professor of biochemistry and molecular medicine, authored a paper published in PLOS ONE outlining the baseline biome of a healthy human gut. This will serve as a reference for doctors, patients, and researchers, giving them an idea of what a “normal” human microbiome looks…
Antonia R. Sepulveda, MD, PhD, has been selected to serve as chair of the Department of Pathology at the GW School of Medicine and Health Sciences. She will also serve as the Ralph E. Lowey Professor of Oncology, as well as chief of pathology service and clinical laboratory director at GW…
Barbara Lee Bass, a widely respected academic medicine leader, surgeon and researcher who completed her residency and served on faculty at the GW, has been named vice president for health affairs and dean of the SMHS.
A team at the GW Cancer Center has identified the protein ERK as an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer.
A new survey published in the Journal of Drugs in Dermatology identifies several barriers that prevent the consistent use of fungal diagnostic preparations to correctly identify cutaneous fungal infections.